What is the primary objective of ISO 37301?

ISO 37301:2021 specifies requirements for establishing, implementing, maintaining, and improving an effective Compliance Management System (CMS). Published on 13 April 2021, it replaces the guidance-only ISO 19600 by introducing certifiable 'shall' requirements, using the Plan-Do-Check-Act (PDCA) cycle and High-Level Structure (HLS) to identify compliance obligations, assess risks, and foster a culture of integrity across all organization sizes and sectors.

Who is legally or professionally required to comply with ISO 37301?

No organizations are legally required to comply with ISO 37301, as it is a voluntary certifiable standard applicable to all types, sizes, and sectors. It is professionally adopted by entities seeking third-party assurance for systematic compliance risk management, including large corporates like Kingspan (multiple sites certified) and SMEs prioritizing regulatory complexity, ESG, and whistleblowing amid stakeholder demands.

Does ISO 37301 require an external audit or third-party certification?

ISO 37301 enables but does not require external audits or third-party certification. Certification is optional via accredited bodies (e.g., ANAB-accredited), involving initial conformity assessment and surveillance audits in a typical three-year cycle, providing verifiable evidence of CMS effectiveness for stakeholders.

How often should an assessment for ISO 37301 be performed?

ISO 37301 requires continual performance evaluation through monitoring, measurement, internal audits, and management reviews at planned intervals. Internal audits are risk-based (frequent for high-risk areas); management reviews occur periodically, feeding into PDCA-driven continual improvement, with certification surveillance typically annually in a three-year cycle.

What are the consequences of non-compliance with ISO 37301?

Non-conformance with ISO 37301 results in loss of certification, if pursued, but no direct legal penalties as it is voluntary. Internally, it risks ineffective CMS leading to regulatory breaches, fines, litigation, or reputational damage; the standard mandates corrective actions, root-cause analysis, and improvement to mitigate such exposures.

Can ISO 37301 be mapped to other international frameworks?

Yes, ISO 37301 follows the High-Level Structure (HLS), enabling seamless mapping and integration with other ISO management system standards. Its PDCA cycle and clauses (context, leadership, planning, support, operation, performance, improvement) support Integrated Management Systems (IMS), companion standards like ISO 37302 (effectiveness) and ISO 37303 (competence), and risk concepts from ISO 31000.

What is the first step to begin implementing ISO 37301?

The first step is securing top management commitment and determining the organization's context per Clause 4. This involves analyzing internal/external issues, identifying interested parties and their expectations, scoping the CMS, and inventorying compliance obligations to build a centralized register, ensuring leadership-driven, risk-based planning.

What is the primary objective of FDA 21 CFR Part 11?

The primary objective of FDA 21 CFR Part 11 is to establish criteria under which the Agency considers electronic records and electronic signatures trustworthy, reliable, and equivalent to paper records and handwritten signatures executed on paper. Per §11.1(a), it ensures authenticity, integrity, confidentiality (when appropriate), and non-repudiation through controls like validation (§11.10(a)), audit trails (§11.10(e)), access limitations (§11.10(d)), and electronic signature requirements (§§11.50–11.300). Systems and documentation must be inspection-ready (§11.1(e)).

Who is legally or professionally required to comply with FDA 21 CFR Part 11?

FDA 21 CFR Part 11 applies to organizations using electronic records created, modified, maintained, archived, retrieved, or transmitted under predicate rules, or submitted electronically to FDA. It targets life sciences firms (pharma, biotech, devices) relying on electronic records in lieu of paper for regulated activities, or where electronic versions are relied upon despite paper existence. Excludes paper records transmitted electronically (§11.1(b)); scope narrows per 2003 guidance based on business reliance.

Does FDA 21 CFR Part 11 require an external audit or third-party certification?

No, FDA 21 CFR Part 11 does not require external audits or third-party certification. Compliance is demonstrated through internal controls, validation, SOPs, and inspection readiness (§11.1(e)). FDA enforces via inspections; predicate rules remain fully applicable. 2003 guidance exercises discretion on some elements but expects enforced controls like access (§11.10(d)) and signatures (§11.100).

How often should an assessment for FDA 21 CFR Part 11 be performed?

FDA 21 CFR Part 11 does not specify a fixed frequency for assessments; they must occur via change control, periodic reviews, and risk-based validation lifecycle. Implement ongoing monitoring through operational checks (§11.10(f)), documentation controls (§11.10(k)), and periodic audit trail reviews. Reassess scope upon system changes, per GAMP lifecycle and predicate rules; FDA expects demonstrable fitness-for-use.

What are the consequences of non-compliance with FDA 21 CFR Part 11?

Non-compliance with FDA 21 CFR Part 11 can result in FDA Form 483 observations, warning letters, product holds, recalls, or injunctions. Predicate rule violations remain enforceable; data integrity failures (e.g., weak audit trails, access controls) lead to enforcement actions, as in warning letters citing inadequate investigations and CAPA. Systems must be inspection-ready (§11.1(e)).

Can FDA 21 CFR Part 11 be mapped to other international frameworks?

Yes, FDA 21 CFR Part 11 controls can be mapped to frameworks like EU Annex 11 for aligned electronic records and signatures. Common mappings include audit trails, validation, and access controls; however, Part 11 scope narrows via 2003 guidance, emphasizing predicate rules over blanket application.

What is the first step to begin implementing FDA 21 CFR Part 11?

The first step to implement FDA 21 CFR Part 11 is to establish a formal applicability framework mapping predicate rules to records and assessing business reliance on electronic versions. Document scope decisions (electronic in lieu of paper? relied upon?) in SOPs per 2003 guidance; classify systems as closed (§11.3(b)(4)) or open (§11.3(b)(9)).

Standards Comparison

ISO 37301 vs FDA 21 CFR Part 11

ISO 37301

Voluntary

2021

International certifiable standard for compliance management systems

FDA 21 CFR Part 11

Mandatory

1997

FDA regulation for trustworthy electronic records and signatures

Quick Verdict

ISO 37301 provides certifiable CMS frameworks for global compliance culture, while FDA 21 CFR Part 11 mandates electronic record/signature controls for US life sciences. Organizations adopt ISO for broad integrity, Part 11 for regulatory equivalence and inspection readiness.

Compliance Management

ISO 37301

ISO 37301:2021 Compliance management systems – Requirements with guidance

Cost

€€€€

Complexity

High

Implementation Time

12-18 months

Key Features

Certifiable standard replacing guidance-only ISO 19600
High-Level Structure enables integration with other ISO standards
Risk-based compliance obligations identification and planning
Mandates leadership commitment and compliance culture
Requires confidential whistleblowing and anti-retaliation protections

Electronic Records

FDA 21 CFR Part 11

21 CFR Part 11 Electronic Records; Electronic Signatures

Cost

€€€€

Complexity

High

Implementation Time

12-18 months

Key Features

Risk-based validation for system accuracy and integrity
Secure, time-stamped audit trails preventing obscuration
Closed/open system controls including encryption
Unique electronic signatures with manifestation and linking
Access, authority, and device checks enforcement

Detailed Analysis

A comprehensive look at the specific requirements, scope, and impact of each standard.

ISO 37301 Details

What It Is

ISO 37301:2021 – Compliance management systems – Requirements with guidance for use is a certifiable international standard for establishing, implementing, maintaining, and improving effective Compliance Management Systems (CMS). It replaces guidance-only ISO 19600, using a risk-based approach and Plan-Do-Check-Act (PDCA) cycle within the ISO High-Level Structure (HLS) for broad applicability across organizations.

Key Components

Core pillars: context analysis, leadership, planning, support, operation, performance evaluation, improvement.
Emphasizes compliance obligations, risk assessment, whistleblowing, competence, and continual improvement.
Built on HLS for integration; companion standards like ISO 37302/37303 provide guidance.
Supports third-party certification via accredited bodies (e.g., ANAB).

Why Organizations Use It

Demonstrates systematic compliance to stakeholders, reduces risks/fines, enhances reputation.
Meets investor/ESG demands; voluntary but provides competitive edge.
Builds integrity culture, early issue detection via whistleblowers.

Implementation Overview

Phased: initiation, design, implementation, measurement, certification.
Applicable to all sizes/sectors; integrates with ISO 9001/14001/27001.
Requires audits in 3-year cycles; 2024 amendment adds climate action.

FDA 21 CFR Part 11 Details

What It Is

FDA 21 CFR Part 11 is a U.S. federal regulation defining criteria for electronic records and electronic signatures to be trustworthy, reliable, and equivalent to paper records and handwritten signatures. It targets FDA-regulated records created, modified, or maintained electronically under predicate rules, using a risk-based approach narrowed by 2003 FDA guidance.

Key Components

**SubpartsGeneral provisions, electronic records (closed/open systems controls), electronic signatures.
Core controls (11+ categories): validation, audit trails, access limits, operational/authority/device checks, training, documentation, signature uniqueness/linking/manifestation.
Built on ALCOA+ principles; enforcement discretion for validation/audit trails but enforces access/signatures.
No formal certification; compliance via inspection readiness.

Why Organizations Use It

Mandatory for life sciences using electronic records in FDA-regulated activities.
Ensures data integrity, non-repudiation; mitigates enforcement risks (warnings, holds).
Drives efficiency, faster inspections, quality improvements; builds stakeholder trust.

Implementation Overview

Phased: scoping (predicate mapping), gap analysis, risk-based validation (IQ/OQ/PQ), SOPs/training, vendor governance.
Applies to pharma/devices/biotech; U.S.-focused; requires ongoing change control/audits. (178 words)

Key Differences

Aspect	ISO 37301	FDA 21 CFR Part 11
Scope	Compliance management systems (CMS) across all obligations	Electronic records/signatures trustworthiness and equivalence
Industry	All sectors, global, all organization sizes	FDA-regulated life sciences, US-focused
Nature	Voluntary certifiable international standard	Mandatory US federal regulation
Testing	Third-party certification audits, internal audits	System validation, FDA inspections
Penalties	Loss of certification, no legal fines	Warning letters, fines, enforcement actions

Scope

ISO 37301

Compliance management systems (CMS) across all obligations

FDA 21 CFR Part 11

Electronic records/signatures trustworthiness and equivalence

Industry

ISO 37301

All sectors, global, all organization sizes

FDA 21 CFR Part 11

FDA-regulated life sciences, US-focused

Nature

ISO 37301

Voluntary certifiable international standard

FDA 21 CFR Part 11

Mandatory US federal regulation

Testing

ISO 37301

Third-party certification audits, internal audits

FDA 21 CFR Part 11

System validation, FDA inspections

Penalties

ISO 37301

Loss of certification, no legal fines

FDA 21 CFR Part 11

Warning letters, fines, enforcement actions

Frequently Asked Questions

Common questions about ISO 37301 and FDA 21 CFR Part 11

ISO 37301 FAQ

FDA 21 CFR Part 11 FAQ

You Might also be Interested in These Articles...

Evidential Readiness Blueprint: Mapping Multi-Cloud Access Controls to Cyber Essentials Audit Requirements

Step-by-step blueprint for IT managers to document and verify access control plus patch management evidence across Microsoft 365, AWS, and Azure for first-time

The Regulatory Radar: How Data-Driven Compliance Tools Provide Strategic Foresight

Unlock strategic foresight with data-driven compliance tools. Act as your regulatory radar: real-time monitoring, automated insights, and 3x cost cuts. Anticipa

Singapore PDPA Implementation Guide: Mastering Part 6A Breach Notification Thresholds and Timelines from Primary Statute

Master Singapore PDPA Part 6A breach notifications: statutory thresholds (risk of significant harm), 72-hour timelines, checklists, templates & frameworks. Comp

Run Maturity Assessments with GRADUM

Transform your compliance journey with our AI-powered assessment platform

Assess your organization's maturity across multiple standards and regulations including ISO 27001, DORA, NIS2, NIST, GDPR, and hundreds more. Get actionable insights and track your progress with collaborative, AI-powered evaluations.

100+ Standards & Regulations

AI-Powered Insights

Collaborative Assessments

Actionable Recommendations

Explore More Comparisons

See how ISO 37301 and FDA 21 CFR Part 11 compare against other standards

Other ISO 37301 Comparisons

Other FDA 21 CFR Part 11 Comparisons

What It Is

Key Components

Core pillars: context analysis, leadership, planning, support, operation, performance evaluation, improvement.

Emphasizes compliance obligations, risk assessment, whistleblowing, competence, and continual improvement.

Built on HLS for integration; companion standards like ISO 37302/37303 provide guidance.

Supports third-party certification via accredited bodies (e.g., ANAB).

What It Is

Key Components

**SubpartsGeneral provisions, electronic records (closed/open systems controls), electronic signatures.

Core controls (11+ categories): validation, audit trails, access limits, operational/authority/device checks, training, documentation, signature uniqueness/linking/manifestation.

Built on ALCOA+ principles; enforcement discretion for validation/audit trails but enforces access/signatures.

No formal certification; compliance via inspection readiness.

Aspect

ISO 37301

FDA 21 CFR Part 11

Scope

Compliance management systems (CMS) across all obligations

Electronic records/signatures trustworthiness and equivalence

Industry

All sectors, global, all organization sizes

FDA-regulated life sciences, US-focused

Nature

Voluntary certifiable international standard

Mandatory US federal regulation

Testing

Third-party certification audits, internal audits

System validation, FDA inspections

Penalties

Loss of certification, no legal fines

Warning letters, fines, enforcement actions